Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

Related Citations for PubMed (Select 23442049)

1.

Sustained inhibition of HIV-1 replication by conditional expression of the E. coli-derived endoribonuclease MazF in CD4+ T cells.

Okamoto M, Chono H, Kawano Y, Saito N, Tsuda H, Inoue K, Kato I, Mineno J, Baba M.

Hum Gene Ther Methods. 2013 Apr;24(2):94-103. doi: 10.1089/hgtb.2012.131. Epub 2013 Mar 28.

PMID:
23442049
2.

Acquisition of HIV-1 resistance in T lymphocytes using an ACA-specific E. coli mRNA interferase.

Chono H, Matsumoto K, Tsuda H, Saito N, Lee K, Kim S, Shibata H, Ageyama N, Terao K, Yasutomi Y, Mineno J, Kim S, Inouye M, Kato I.

Hum Gene Ther. 2011 Jan;22(1):35-43. doi: 10.1089/hum.2010.001. Epub 2010 Dec 12.

PMID:
20649483
3.

In vivo safety and persistence of endoribonuclease gene-transduced CD4+ T cells in cynomolgus macaques for HIV-1 gene therapy model.

Chono H, Saito N, Tsuda H, Shibata H, Ageyama N, Terao K, Yasutomi Y, Mineno J, Kato I.

PLoS One. 2011;6(8):e23585. doi: 10.1371/journal.pone.0023585. Epub 2011 Aug 17.

4.

Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.

Braun SE, Wong FE, Connole M, Qiu G, Lee L, Gillis J, Lu X, Humeau L, Slepushkin V, Binder GK, Dropulic B, Johnson RP.

Mol Ther. 2005 Dec;12(6):1157-67. Epub 2005 Sep 15.

PMID:
16168713
5.

A mutant Tat protein provides strong protection from HIV-1 infection in human CD4+ T cells.

Apolloni A, Lin MH, Sivakumaran H, Li D, Kershaw MH, Harrich D.

Hum Gene Ther. 2013 Mar;24(3):270-82. doi: 10.1089/hum.2012.176. Epub 2013 Mar 1.

6.
7.

Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells and monocytes derived from CD34+ cells transduced with an intracellular antibody directed against human immunodeficiency virus type 1 Tat.

Poznansky MC, La Vecchio J, Silva-Arietta S, Porter-Brooks J, Brody K, Olszak IT, Adams GB, Ramstedt U, Marasco WA, Scadden DT.

Hum Gene Ther. 1999 Oct 10;10(15):2505-14.

PMID:
10543615
8.

Impact of sustained RNAi-mediated suppression of cellular cofactor Tat-SF1 on HIV-1 replication in CD4+ T cells.

Green VA, Arbuthnot P, Weinberg MS.

Virol J. 2012 Nov 15;9:272. doi: 10.1186/1743-422X-9-272.

9.

Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.

Lisziewicz J, Sun D, Smythe J, Lusso P, Lori F, Louie A, Markham P, Rossi J, Reitz M, Gallo RC.

Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8000-4.

10.

A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.

Macías D, Oya R, Saniger L, Martín F, Luque F.

Hum Gene Ther. 2009 Nov;20(11):1259-68. doi: 10.1089/hum.2009.059.

PMID:
19604078
11.

Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies.

Mhashilkar AM, LaVecchio J, Eberhardt B, Porter-Brooks J, Boisot S, Dove JH, Pumphrey C, Li X, Weissmahr RN, Ring DB, Ramstedt U, Marasco WA.

Hum Gene Ther. 1999 Jun 10;10(9):1453-67.

PMID:
10395371
12.
14.

Cross-clade inhibition of HIV-1 replication and cytopathology by using RNase P-associated external guide sequences.

Kraus G, Geffin R, Spruill G, Young AK, Seivright R, Cardona D, Burzawa J, Hnatyszyn HJ.

Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3406-11.

15.

Protection of primary human T cells from HIV infection by Trev: a transdominant fusion gene.

Chinen J, Aguilar-Cordova E, Ng-Tang D, Lewis DE, Belmont JW.

Hum Gene Ther. 1997 May 1;8(7):861-8.

PMID:
9143912
16.

High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.

Plavec I, Agarwal M, Ho KE, Pineda M, Auten J, Baker J, Matsuzaki H, Escaich S, Bonyhadi M, Böhnlein E.

Gene Ther. 1997 Feb;4(2):128-39.

17.

MazF-expressing T cells could suppress HIV replication.

[No authors listed]

Immunotherapy. 2011 Mar;3(3):310. No abstract available.

PMID:
21520506
18.

Intramolecular regulation of the sequence-specific mRNA interferase activity of MazF fused to a MazE fragment with a linker cleavable by specific proteases.

Park JH, Yamaguchi Y, Inouye M.

Appl Environ Microbiol. 2012 Jun;78(11):3794-9. doi: 10.1128/AEM.00364-12. Epub 2012 Mar 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk